Performance Report

The report describes Boston Scientific's 2021 ESG performance across patient care, people, climate and responsible business. Key environmental highlights include exceeding the 50% renewable-electricity interim target, reaching 73% renewable electricity and committing to net-zero carbon emissions across the value chain by 2050. The company also reports an A- CDP score, board-level ESG oversight and preparation in accordance with the GRI Standards: Core option.